Suite of digital and data solutions designed
to improve clinical trial efficiency, reduce data delays and
simplify investigator site workflows
BURLINGTON, N.C. ,
June 17,
2024 /PRNewswire/ -- Labcorp (NYSE: LH), a
global leader of innovative and comprehensive laboratory services,
announced today the launch of Labcorp Global Trial Connect, a suite
of central laboratory solutions aimed at increasing the speed of
clinical trials where the heart of clinical research is conducted –
investigator sites.
"The patient-investigator-biopharma sponsor relationship is at
the foundation of a successful clinical trial. Global Trial Connect
simplifies the investigator workflow, improves the patient
experience and ultimately enables biopharma sponsors to bring
therapies to market faster," said Jon
DiVincenzo, EVP and President, Central Laboratories and
International at Labcorp. "As the world's leading central
laboratory, Labcorp is dedicated to improving the pace of clinical
trials focusing on the investigator site experience from study
initiation to patient recruitment and data collection."
Labcorp Global Trial Connect, available to current Labcorp
Central Laboratory clients, incorporates complementary digital and
data solutions that help accelerate clinical study startup,
maintain study momentum and increase study throughput. Capabilities
include:
- Site enablement resources – to identify new study
opportunities, enhance patient access and recruitment and improve
diversity in clinical trials.
- Supply readiness support – to increase study startup
efficiencies, reduce trial delays and reduce supply and kit
waste.
- Site workflow facilitation – to help integrate sample
collection and tracking data, provide visibility and actionable
analytics to both sites and sponsors, and reduce errors, queries,
holds and data revisions through eRequisition functionality.
- Study management and investigator support – to
accelerate study startup and maintain study momentum with 24/7 site
support and on-demand tools and trainings.
For more information,
visit LabcorpGlobalTrialConnect.com.
About Labcorp
Labcorp (NYSE: LH) is a global leader of
innovative and comprehensive laboratory services that helps
doctors, hospitals, pharmaceutical companies, researchers and
patients make clear and confident decisions. We provide insights
and advance science to improve health and improve lives through our
unparalleled diagnostics and drug development laboratory
capabilities. The company's more than 67,000 employees serve
clients in approximately 100 countries, provided support for 84% of
the new drugs and therapeutic products approved in 2023 by the FDA,
and performed more than 600 million tests for patients around the
world. Learn more about us at www.labcorp.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/labcorp-launches-global-trial-connect-to-accelerate-clinical-trials-302174129.html
SOURCE Labcorp